Author Question: A weight-loss ad claims, Lose up to five pounds per week. Is this statement a basis for ... (Read 76 times)

SO00

  • Hero Member
  • *****
  • Posts: 568
A weight-loss ad claims, Lose up to five pounds per week. Is this statement a basis for misrepresentation?

Question 2

A director who usurps a corporate opportunity:
 A) will owe his/her corporation the profits from the opportunity.
 B) will not owe the profits to the corporation so long as the venture was disclosed in advance.
 C) has violated the business judgment rule.
 D) None of the above



pikon

  • Sr. Member
  • ****
  • Posts: 361
Answer to Question 1

Yes, the statement could be a basis for misrepresentation, but it is open-ended enough that there may not be any action against the company for making it. The statement does not guarantee five pounds per week - it is only up to. If anything, the statement is only placing a maximum on weight loss.

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Not getting enough sleep can greatly weaken the immune system. Lack of sleep makes you more likely to catch a cold, or more difficult to fight off an infection.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library